Monsanto Claims to Ditch Herbicide While Selling More of It

Roundup, the usual suspect. <a href="http://www.flickr.com/photos/27023836@N00/542526620/">efwp</a>/Flickr

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


Genetically modified seed giant Monsanto likes to trumpet its “commitment to sustainable agriculture. The story goes like this: by generating novel, high-tech crop varieties, Monsanto will wean farmers off of synthetic chemical poisons. The company even markets its flagship product, seeds genetically engineered to survive its own Roundup weed killer, as a tool they can use to to “decrease the overall use of herbicides.”

But as I’ve shown before, herbicide use has actually dramatically ramped up as the Roundup Ready technology conquers vast swaths of US farmland. That’s because weeds quickly developed resistance to it, forcing farmers to apply ever-larger doses and resort to older, more toxic herbicides to combat resistant weeds. And while the company has tried hard to leave behind its past as a purveyor of toxic chemicals and rebrand itself as a technology company, those toxic chemicals remain central to its growth and profitability, as its latest quarterly profit report shows.

The report—press release here—cheered investors, driving Monsanto shares to their highest levels since 2008. Here’s the main bit, lifted from the press release (note that by “second quarter,” the company means the January to March period):

Monsanto’s latest earnings report—all about corn and “ag productivity” (herbicides) Detail from a Monsanto press release.

Note that the company consists of two main segments: what it calls “Seeds and Genomics,” which involves sales of seeds, obviously, plus licensing fees on genetically modified traits; and “Agricultural Productivity,” which means, essentially, chemicals, mainly Roundup in a variety of forms. Seeds and Genomics is by far the largest of the two in terms of contribution to overall sales, but good old Agricultural Productivity is still really important. Indeed, its sales shot up from $824 million in second-quarter 2012 to $1.12 billion in the same time period of this year—that’s an amazing 36 percent jump.

By contrast, Seeds and Genomics sales went from $3.92 billion to $4.35 billion over the same time span—just a 10 percent rise.

Overall, the herbicide contribution to Monsanto’s total sales went from 17 percent in second-quarter 2012 to 20 percent in the the same period of 2013.

Let’s dig a little deeper into the Seeds and Genomics part of the above chart. Note that for every business line but one—corn seed and traits—sales declined in second-quarter 2013 compared to the same period of a year before. Monsanto’s corn business is booming—sales went from $2.816 billion to $3.28 billion—a 16 percent gain. Everything else, though—soybeans, cotton, vegetables, etc.—stagnated. (And the same trend holds true when you look at the six-month comparison, also shown in the above chart.).

In short, Monsanto’s growth now depends largely on corn and Roundup.

Widespread use of Bt corn did reduce insecticide use for several years, but certain insects are now developing resistance to it.

The press release does not exactly trumpet the fact that Roundup plays a massive role in driving its growth. But it does declare that “the company remains focused on its established Roundup® strategy.” I’ll say.

But Roundup isn’t Monsanto’s only strategy triggering an surge in chemical use. Most of the corn seed Monsanto sells is engineered to contain a gene from Bacillus thuringiensis (Bt), a soil bacteria that’s toxic to bugs. Widespread use of Bt corn did indeed reduce insecticide use on corn for several years, but as I’ve reported before, certain insects are developing resistance to it. Predictably, farmers are planning to react by resorting to chemical pesticides, according to Michael Gray, an entomology professor at University of Illinois who polls farmers on planting decisions. Here’s the trade magazine Ag Professional:

Gray also said that in 2013, he anticipates a sharp increase in the use of planting-time soil insecticides with corn rootworm Bt hybrids. On average, nearly half the producers indicated they intend to use both a soil applied (at-planting) insecticide with their corn rootworm Bt hybrid this spring.

“From my perspective, the escalation of soil insecticide use along with corn rootworm Bt hybrids has been fueled primarily by concerns about Bt resistance and high commodity prices,” he said. [Emphasis added.]

Far from ushering in an era of widespread sustainable agriculture, Monsanto and its products are keeping farmers stranded on what ecologists call a “pesticide treadmill”—never-ending chemical warfare against fast-adapting ecosystems.

AN IMPORTANT UPDATE ON MOTHER JONES' FINANCES

We need to start being more upfront about how hard it is keeping a newsroom like Mother Jones afloat these days.

Because it is, and because we're fresh off finishing a fiscal year, on June 30, that came up a bit short of where we needed to be. And this next one simply has to be a year of growth—particularly for donations from online readers to help counter the brutal economics of journalism right now.

Straight up: We need this pitch, what you're reading right now, to start earning significantly more donations than normal. We need people who care enough about Mother Jones’ journalism to be reading a blurb like this to decide to pitch in and support it if you can right now.

Urgent, for sure. But it's not all doom and gloom!

Because over the challenging last year, and thanks to feedback from readers, we've started to see a better way to go about asking you to support our work: Level-headedly communicating the urgency of hitting our fundraising goals, being transparent about our finances, challenges, and opportunities, and explaining how being funded primarily by donations big and small, from ordinary (and extraordinary!) people like you, is the thing that lets us do the type of journalism you look to Mother Jones for—that is so very much needed right now.

And it's really been resonating with folks! Thankfully. Because corporations, powerful people with deep pockets, and market forces will never sustain the type of journalism Mother Jones exists to do. Only people like you will.

There's more about our finances in "News Never Pays," or "It's Not a Crisis. This Is the New Normal," and we'll have details about the year ahead for you soon. But we already know this: The fundraising for our next deadline, $350,000 by the time September 30 rolls around, has to start now, and it has to be stronger than normal so that we don't fall behind and risk coming up short again.

Please consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

—Monika Bauerlein, CEO, and Brian Hiatt, Online Membership Director

payment methods

AN IMPORTANT UPDATE ON MOTHER JONES' FINANCES

We need to start being more upfront about how hard it is keeping a newsroom like Mother Jones afloat these days.

Because it is, and because we're fresh off finishing a fiscal year, on June 30, that came up a bit short of where we needed to be. And this next one simply has to be a year of growth—particularly for donations from online readers to help counter the brutal economics of journalism right now.

Straight up: We need this pitch, what you're reading right now, to start earning significantly more donations than normal. We need people who care enough about Mother Jones’ journalism to be reading a blurb like this to decide to pitch in and support it if you can right now.

Urgent, for sure. But it's not all doom and gloom!

Because over the challenging last year, and thanks to feedback from readers, we've started to see a better way to go about asking you to support our work: Level-headedly communicating the urgency of hitting our fundraising goals, being transparent about our finances, challenges, and opportunities, and explaining how being funded primarily by donations big and small, from ordinary (and extraordinary!) people like you, is the thing that lets us do the type of journalism you look to Mother Jones for—that is so very much needed right now.

And it's really been resonating with folks! Thankfully. Because corporations, powerful people with deep pockets, and market forces will never sustain the type of journalism Mother Jones exists to do. Only people like you will.

There's more about our finances in "News Never Pays," or "It's Not a Crisis. This Is the New Normal," and we'll have details about the year ahead for you soon. But we already know this: The fundraising for our next deadline, $350,000 by the time September 30 rolls around, has to start now, and it has to be stronger than normal so that we don't fall behind and risk coming up short again.

Please consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

—Monika Bauerlein, CEO, and Brian Hiatt, Online Membership Director

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate